Please login to the form below

How to design patient services with social media within the ABPI code guidelines

In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.



In the UK, the marketing of prescription medicine to health professionals and patients is carried out under strict regulatory oversight to protect and support high quality patient care. The ABPI Code of Practice for the Pharmaceutical Industry is administered by the Prescription Medicines Code of Practice Authority, and is a self-regulatory code that applies to the marketing of prescription medicines both to health professionals and the public as a whole.


When designing digital services and informational materials for prescription drugs or services, there are unique considerations that must be taken around how that information is accessed and used. In this blog, Senior Consultant Craig Moore, from the Blue Latitude Strategy team, discusses the application of the ABPI Code, including incorporating social media into digital patient services.


Do some 
market research to understand the customer needs: would patients be interested in the social media functionality; would they use it? Rounds of user research and user testing would highlight if this was important or not.
At Blue Latitude, the aim is to solve problems for clients following a number of solution design methodologies.

Host a 
PMCPA (Prescription Medicines Code of Practice Authority) training session and take the opportunity to get feedback on early solution concepts. Understand where other companies have breached the code and where you may run the risk with your own solutions. The PMCPA’s view is absolute; any company working with or providing services for the Pharma Industry needs to know the code. (Blue Latitude’s staff have all completed the introductory PMCPA training session).


Get cross-functional teams around a meeting table 
to highlight social media in the organisation. The corporate communication team handles social throughout most organisations. Silos mean that the information is not always shared. The development of the website/app should not be the main focus; the main focus should be to capture any company-wide issues or concerns about using social, and highlight areas of the code that are designed to support this. Take any objections away and incorporate them into the business case for the solution.


Consider the level of patient access
 in the kind of website/app you want to develop. Patient access will raise some red flags, especially from the pharma-covigilance teams. The fear would be that an increased perception of patients discussing product-related issues would lead to an inundation of Adverse Events or Product Complaints (AE/PC).

Initiate some monitoring pilots related to the therapy area
 in general. This will help establish a reporting process; defining clear roles and responsibilities as well as outlining clear project plans, objectives, and exit strategies. Always follow the guidelines, and go beyond them.


For example, use what you report (or consider to be) an AE/PC as a metric to demonstrate that social listening will not create an undue burden on internal resources. Once the process is established, expand monitoring into competitor products – there is no need to report AE/PC for competitors – then, move on to company-owned products.

Look at the possibility of developing a solution for closed patient communities
. The code explains how use of social media to discuss prescription medicines (for example, on Twitter) is seen as promotional. With closed patient communities, the challenge to the code/internal MLR compliance teams is to make sure to only allow access to prescribed patients. Canada, for example, uses product identification numbers and DIN to allow access to a patient programme or forum.


If you’d like to discuss digital solutions for patient communities or how the ABPI Code impacts digital services in more depth, we’d love to hear from youGet in touch!

To read more about regulations which impact marketing for Pharma, read our blog from guest poster Aurelie Pols on data security and privacy.

21st May 2015

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Q&A with Dr Timothy Vollmer, leading MS Neurologist
Blue Latitude Health sits down with key opinion leader and specialist neurologist Dr Timothy Vollmer to better understand the paradigm shift in MS treatment. He explains the challenges neurologists face when making treatment decisions, and why patients need to be treated with more efficacious drugs earlier on.
Blue Latitude Health
Living my best life with multiple sclerosis
Multi-award-winning advocate and patient engagement champion Trishna Bharadia gives a valuable insight into life with multiple sclerosis. She explains how treatment has changed, how our healthcare systems and pharma can unite to improve quality of life for MS patients today, and why her diagnosis isn’t stopping her achieving her goals.
Blue Latitude Health
Creative review: ESMO 2018
BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring design for your booth.
Blue Latitude Health
A unique tool for turning data into brand strategy
Head of Insight Martine Leroy, uses her 25+ years’ experience to develop an exclusive perceptual framework for research design and analysis, which generates a deeper understanding of customer needs and the changing market dynamics
Blue Latitude Health
Positive disruption: getting to the bottom of big data
BLH speaks to Nicole Huyghe, founder and Managing Director of data science consultancy Boobook, about the growing need from businesses for data-driven decision making.
Blue Latitude Health
We've moved!
Blue Latitude Health has moved office to a new location in Barbican, Central London, following a year of substantial growth.
Blue Latitude Health